Introducing Palliative Care (PC) Within the Treatment of End Stage Liver Disease (ESLD)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Manisha Verma, MD, MPH
Albert Einstein Healthcare Network
Principal Investigator - Victor Navarro, MD
Albert Einstein Healthcare Network
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama
Birmingham, Alabama, United States
- Banner Health- University Medical Center
Phoenix, Arizona, United States
- Ucsf Fresno
Fresno, California, United States
- Loma Linda Unversity Health
Loma Linda, California, United States
- Va West Haven
West Haven, Connecticut, United States
- University of Florida
Gainesville, Florida, United States
- Miami Va Medical Center
Miami, Florida, United States
- Indiana University
Indianapolis, Indiana, United States
- Va Boston
Boston, Massachusetts, United States
- University of Michigan Medical Center
Ann Arbor, Michigan, United States
- Kansas City Va Medical Center
Kansas City, Missouri, United States
- Va New York Harbor
Brooklyn, New York, United States
- Va Bronx
The Bronx, New York, United States
- Unc Liver Center
Chapel Hill, North Carolina, United States
- Durham V.A. Medical Center
Durham, North Carolina, United States
- Albert Einstein Medical Center
Philadelphia, Pennsylvania, United States
- Corporal Michael J. Crescenz Va Medical Center
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Baylor College of Medicine
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jan 2019
- Primary completion
- 30 Jun 2025
- Completion
- 30 Aug 2025
- Last update posted
- 2 Dec 2025
- Registered enrollment
- 1,494
- Registry id
- NCT03540771
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.